YME1L1 and central nervous system cancer: In addition, the CellROX intensity was significantly increased in YME1L-depleted P1 glioma cells (Fig. S3B), suggesting that mitochondria-derived reactive oxygen species (ROS) contents were significantly increased with YME1L silencing or KO.